Emerald Advisers, LLC Horizon Therapeutics Public LTD CO Transaction History

Emerald Advisers, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$96.34 - $112.38 $253,855 - $296,121	2,635 New	2,635 $271,000
Q3 2022 Oct 25, 2022	SELL	$58.92 - $84.67 $502,351 - $721,896	-8,526 Reduced 26.64%	23,478 $1.45 Million
Q2 2022 Jul 29, 2022	BUY	$79.4 - $116.36 $117,670 - $172,445	1,482 Added 4.86%	32,004 $2.55 Million
Q1 2022 Apr 29, 2022	BUY	$86.42 - $109.81 $93,592 - $118,924	1,083 Added 3.68%	30,522 $3.21 Million
Q4 2021 Feb 02, 2022	SELL	$98.56 - $119.91 $237,135 - $288,503	-2,406 Reduced 7.56%	29,439 $3.17 Million

Q3 2021 Oct 28, 2021	SELL	$91.91 - $110.37 $77,112 - $92,600	-839 Reduced 2.57%	31,845 $3.49 Million
Q1 2021 Apr 29, 2021	SELL	$71.83 - $95.48 $1.25 Million - $1.67 Million	-17,440 Reduced 34.79%	32,684 $3.01 Million
Q4 2020 Jan 29, 2021	SELL	$67.0 - $84.39 $39.5 Million - $49.7 Million	-589,441 Reduced 92.16%	50,124 $3.67 Million
Q3 2020 Oct 28, 2020	SELL	$55.23 - $79.93 $12.4 Million - $18 Million	-225,325 Reduced 26.05%	639,565 $49.7 Million
Q2 2020 Jul 28, 2020	SELL	$30.2 - $56.98 $10.9 Million - $20.5 Million	-360,306 Reduced 29.41%	864,890 $48.1 Million
Q1 2020 Apr 30, 2020	BUY	$24.87 - $38.56 $454,175 - $704,182	18,262 Added 1.51%	1,225,196 $36.3 Million
Q4 2019 Jan 29, 2020	SELL	$25.43 - $36.67 $15,893 - $22,918	-625 Reduced 0.05%	1,206,934 $43.7 Million
Q3 2019 Oct 31, 2019	SELL	$23.0 - $27.97 $2.38 Million - $2.9 Million	-103,519 Reduced 7.9%	1,207,559 $32.9 Million
Q2 2019 Jul 31, 2019	BUY	$22.81 - $28.48 $29.9 Million - $37.3 Million	1,311,078 New	1,311,078 $31.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.